{"id":"dhp","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Edema"},{"rate":"1-5%","effect":"Headache"},{"rate":"1-5%","effect":"Dizziness"},{"rate":"1-5%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL151098","moleculeType":"Small molecule","molecularWeight":"641.77"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DHP acts on the L-type calcium channels in vascular smooth muscle cells, leading to vasodilation and decreased peripheral resistance. This results in a decrease in blood pressure and a reduction in the workload on the heart.","oneSentence":"DHP is a dihydropyridine calcium channel blocker that works by relaxing blood vessels and reducing blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:31:45.568Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"}]},"trialDetails":[{"nctId":"NCT03890666","phase":"PHASE4","title":"A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2020-10-26","conditions":"Asthma","enrollment":333},{"nctId":"NCT07447297","phase":"NA","title":"Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2024-01-02","conditions":"Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter","enrollment":520},{"nctId":"NCT07445334","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes","status":"NOT_YET_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2026-03-01","conditions":"Premature Ventricular Complexes, Premature Ventricular Contraction (PVC), Premature Ventricular Beats","enrollment":40},{"nctId":"NCT07272902","phase":"NA","title":"Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2026-01-01","conditions":"Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":84},{"nctId":"NCT07369128","phase":"PHASE4","title":"Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-02","conditions":"MRI Sedation, Pediatric Sedation, Propofol Dosage","enrollment":105},{"nctId":"NCT03901807","phase":"NA","title":"Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Spectral Diagnostics (US) Inc.","startDate":"2020-01-09","conditions":"Septic Shock, Endotoxemia","enrollment":150},{"nctId":"NCT05489705","phase":"","title":"A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2022-08-16","conditions":"Obstructive Hypertrophic Cardiomyopathy","enrollment":1600},{"nctId":"NCT05125224","phase":"","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Dihydropyridine Calcium Channel Blockers Versus Hydrochlorothiazide","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2021-10-01","conditions":"Hypertension","enrollment":163720},{"nctId":"NCT06242080","phase":"NA","title":"SMILE: Clinical Trial to Evaluate Mindfulness as Intervention for Racial and Ethnic Populations During COVID-19","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-05-13","conditions":"Anxiety, COVID-19 Pandemic","enrollment":369},{"nctId":"NCT06808321","phase":"","title":"Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients","status":"ENROLLING_BY_INVITATION","sponsor":"The Society of Prevention and Awareness of Cardiovascular Diseases","startDate":"2025-03-01","conditions":"Chronic Coronary Syndrome, Hypertension, Angina Pectoris","enrollment":800},{"nctId":"NCT05343312","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2022-03-16","conditions":"Malaria","enrollment":870},{"nctId":"NCT04864145","phase":"NA","title":"Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2021-05-21","conditions":"Aortic Valve Disease","enrollment":210},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT05130268","phase":"PHASE4","title":"Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation","status":"COMPLETED","sponsor":"American Heart Association","startDate":"2021-10-29","conditions":"Atrial Fibrillation","enrollment":339},{"nctId":"NCT06556732","phase":"PHASE1","title":"Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease","status":"RECRUITING","sponsor":"Assiut University","startDate":"2024-08-10","conditions":"Atrial Fibrillation","enrollment":100},{"nctId":"NCT06265415","phase":"NA","title":"Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-03-30","conditions":"Severe Preeclampsia","enrollment":60},{"nctId":"NCT05241288","phase":"NA","title":"Digihaler in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-03-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":54},{"nctId":"NCT06130527","phase":"NA","title":"Comparison of the Effects of Nicardipine and Remifentanil on Surgical Visual Field","status":"UNKNOWN","sponsor":"Erol Karaaslan","startDate":"2023-11-30","conditions":"Other Complications of Surgical and Medical Procedures","enrollment":64},{"nctId":"NCT04767191","phase":"PHASE4","title":"Malaria Therapeutic Efficacy Study (TES) Kenya","status":"COMPLETED","sponsor":"Jhpiego","startDate":"2021-03-15","conditions":"Uncomplicated Malaria","enrollment":400},{"nctId":"NCT06036030","phase":"PHASE2","title":"Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua","status":"COMPLETED","sponsor":"Syamsudin Abdillah,Ph.D, Pharm D","startDate":"2019-01-11","conditions":"Malaria,Falciparum, Malaria, Vivax, Malaria","enrollment":50},{"nctId":"NCT03827889","phase":"NA","title":"Efficacy of Two Protocols for Applying Fluorine Varnish to Deciduous Teeth","status":"SUSPENDED","sponsor":"Universidade Ibirapuera","startDate":"2024-01-01","conditions":"Dental Caries","enrollment":168},{"nctId":"NCT04677959","phase":"PHASE4","title":"A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2021-02-16","conditions":"Asthma","enrollment":427},{"nctId":"NCT03082014","phase":"PHASE3","title":"Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function","status":"TERMINATED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2018-02-22","conditions":"Cerebral Small Vessel Diseases","enrollment":101},{"nctId":"NCT05537194","phase":"","title":"Effects of Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas Exchanges in the Intensive Care Unit: a Pharmacovigilance Study in VigiBase® and a Comparison With Urapidil","status":"COMPLETED","sponsor":"University Hospital, Caen","startDate":"1963-01-01","conditions":"Hypoxia","enrollment":32000000},{"nctId":"NCT04542785","phase":"NA","title":"Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation. The Danish Atrial Fibrillation Randomised Clinical Trial","status":"UNKNOWN","sponsor":"Holbaek Sygehus","startDate":"2021-03-31","conditions":"Atrial Fibrillation, Persistent, Atrial Fibrillation Chronic, Atrial Fibrillation","enrollment":350},{"nctId":"NCT04191681","phase":"PHASE4","title":"Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2019-11-08","conditions":"Stage D Heart Failure","enrollment":50},{"nctId":"NCT04364139","phase":"PHASE3","title":"African American Study of Kidney Disease and Hypertension","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1995-02-01","conditions":"Hypertensive Nephrosclerosis, Chronic Renal Insufficiency","enrollment":1094},{"nctId":"NCT00283686","phase":"PHASE3","title":"HALT Progression of Polycystic Kidney Disease Study A","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2006-01","conditions":"Kidney, Polycystic","enrollment":558},{"nctId":"NCT01388595","phase":"PHASE4","title":"Fluticasone and Salmeterol in Allergic Rhinitis","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2006-11","conditions":"Allergic Rhinitis","enrollment":23},{"nctId":"NCT04092621","phase":"PHASE4","title":"Rapid Atrial Fibrillation Treatment Strategy","status":"UNKNOWN","sponsor":"Our Lady of the Lake Hospital","startDate":"2019-09-16","conditions":"New Onset Atrial Fibrillation, Sepsis, Respiratory Failure","enrollment":40},{"nctId":"NCT02412761","phase":"NA","title":"Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-06","conditions":"Essential Hypertension","enrollment":42},{"nctId":"NCT03371797","phase":"","title":"Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial","status":"COMPLETED","sponsor":"PharmEvo Pvt Ltd","startDate":"2018-02-20","conditions":"Essential Hypertension","enrollment":800},{"nctId":"NCT02001428","phase":"NA","title":"Malaria in Early Life Study","status":"COMPLETED","sponsor":"Gadjah Mada University","startDate":"2014-07-21","conditions":"Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria","enrollment":757},{"nctId":"NCT02298556","phase":"","title":"An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes","status":"COMPLETED","sponsor":"Abbott","startDate":"2014-10","conditions":"Hypertension","enrollment":270},{"nctId":"NCT00858702","phase":"PHASE4","title":"Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension","status":"COMPLETED","sponsor":"Daiichi Sankyo Co., Ltd.","startDate":"2005-02","conditions":"Hypertension","enrollment":105},{"nctId":"NCT02088450","phase":"PHASE2","title":"Systolic Hypertension in Europe Placebo-Controlled Trial","status":"TERMINATED","sponsor":"KU Leuven","startDate":"1990-02","conditions":"Isolated Systolic Hypertension","enrollment":4695},{"nctId":"NCT02353494","phase":"","title":"Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria","status":"COMPLETED","sponsor":"Menzies School of Health Research","startDate":"2015-03","conditions":"Plasmodium Falciparum Infection, Plasmodium Vivax Infection","enrollment":130},{"nctId":"NCT02646397","phase":"PHASE4","title":"Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension","status":"UNKNOWN","sponsor":"Shanghai Changzheng Hospital","startDate":"2016-02","conditions":"Chronic Kidney Disease","enrollment":508},{"nctId":"NCT01878357","phase":"PHASE4","title":"Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2013-06","conditions":"Malaria","enrollment":1488},{"nctId":"NCT01288820","phase":"PHASE3","title":"Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2011-01","conditions":"Vivax Malaria","enrollment":331},{"nctId":"NCT00637078","phase":"PHASE4","title":"STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)","status":"COMPLETED","sponsor":"University of Western Ontario, Canada","startDate":"2008-02","conditions":"Hypertension, Hypercholesterolemia","enrollment":1000},{"nctId":"NCT01389557","phase":"PHASE4","title":"Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatra","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2011-02","conditions":"Malaria","enrollment":77},{"nctId":"NCT01392014","phase":"PHASE4","title":"Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2008-12","conditions":"Malaria","enrollment":374},{"nctId":"NCT01046032","phase":"NA","title":"Metformin Treatment Before in Vitro Fertilization (IVF) in Women With Ultrasound Evidence of Polycystic Ovaries","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2005-12","conditions":"Polycystic Ovary Syndrome","enrollment":134}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"RESTLESS LEGS SYNDROME"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"DHP","genericName":"DHP","companyName":"Centro de Investigacao em Saude de Manhica","companyId":"centro-de-investigacao-em-saude-de-manhica","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DHP is a dihydropyridine calcium channel blocker that works by relaxing blood vessels and reducing blood pressure. Used for Hypertension, Angina pectoris.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}